REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US): PB1809